Harbour Investments Inc. Buys 32 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Harbour Investments Inc. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,544 shares of the medical equipment provider’s stock after buying an additional 32 shares during the quarter. Harbour Investments Inc.’s holdings in Intuitive Surgical were worth $806,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Centurion Wealth Management LLC lifted its position in shares of Intuitive Surgical by 6.8% in the fourth quarter. Centurion Wealth Management LLC now owns 976 shares of the medical equipment provider’s stock worth $509,000 after purchasing an additional 62 shares in the last quarter. Avalon Trust Co raised its position in Intuitive Surgical by 29.9% during the fourth quarter. Avalon Trust Co now owns 721 shares of the medical equipment provider’s stock worth $376,000 after acquiring an additional 166 shares in the last quarter. Choate Investment Advisors raised its position in Intuitive Surgical by 61.8% during the fourth quarter. Choate Investment Advisors now owns 2,370 shares of the medical equipment provider’s stock worth $1,237,000 after acquiring an additional 905 shares in the last quarter. M & L Capital Management Ltd bought a new stake in Intuitive Surgical during the fourth quarter worth $9,239,000. Finally, Frank Rimerman Advisors LLC raised its position in Intuitive Surgical by 0.6% during the fourth quarter. Frank Rimerman Advisors LLC now owns 10,890 shares of the medical equipment provider’s stock worth $5,684,000 after acquiring an additional 60 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.7 %

ISRG opened at $492.06 on Thursday. The company’s 50 day moving average is $564.39 and its 200-day moving average is $531.62. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market cap of $175.26 billion, a P/E ratio of 76.76, a PEG ratio of 5.85 and a beta of 1.43.

Insider Activity

In other news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on ISRG shares. Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. CICC Research assumed coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Bernstein Bank increased their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Finally, Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.